Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Aspirin Use and Bleeding Volume in Skin Cancer Patients Undergoing Surgery: A Randomized Controlled Trial Publisher Pubmed



Engheta A1 ; Abianeh SH2 ; Atri A1 ; Sanatkarfar M3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Plastic Surgery, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Plastic Surgery, Razi Hospital, Tehran University of Medical Sciences, Vahdat Eslami st, Tehran, Iran
  3. 3. Department of Anesthesiology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: DARU# Journal of Pharmaceutical Sciences Published:2016


Abstract

We investigated the occurrence of bleeding complications in patients who underwent skin tumor surgery and compared it between Aspirin users and a placebo control group. In this double blind randomized controlled trial, 32 patients who continued taking aspirin (intervention group) and 38 patients who stopped taking Aspirin (placebo group) before surgery were compared in terms of intraoprative and postoperative bleeding problems, hematoma and local signs of coagulopathy. There was no statistically significant difference in intraoprative bleeding between the study groups (P = 0.107). We concluded that continuation of Aspirin therapy had no significant effect on bleeding complications in patients who underwent skin tumor surgery. © 2016 The Author(s).